Quest, Labcorp Tout Their Alzheimer’s Tests and Use of AI

By Mark Terry | From the Volume XXXII, No. 17 – December 8, 2025 Issue

Executives at Quest Diagnostics and Labcorp cheered strong revenue growth in the third quarter. Both companies noted excellent recent launches of Alzheimer’s disease tests. In addition, both companies reported they are leaning heavily into artificial intelligen…

Read More

---

Quest, Labcorp Discuss PAMA and M&A with Investors

By Mark Terry | From the Volume XXXII, No. 13 – September 15, 2025 Issue

WHILE LAUDING EXCELLENT GROWTH FOR THE SECOND QUARTER, executives at Labcorp and Quest Diagnostics also expressed concern over the Protecting Access to Medicare Act (PAMA), which was passed by Congress in 2014 and which continues to cause uncertainty as full implementation is repeatedly…

Read More

---

Quest Diagnostics, Labcorp Issue Q4 and Full Year 2024 Earnings

By Robert Michel | From the Volume XXXII, No. 3 – February 17, 2025 Issue

LAB ACQUISITIONS IN 2024 WERE A CONTRIBUTING FACTOR TO REVENUE GROWTH at the nation’s two biggest clinical laboratory companies. This was reflected in the fourth quarter and full year 2024 earnings reports issued by Labcorp and Quest Diagnostics. Here are recently …

Read More

---

Insights from Q3 2024 Earnings Calls Point to a More Robust Lab Market

By Robert Michel | From the Volume XXXI No. 15 – November 4, 2024 Issue

FOR THE THIRD QUARTER OF 2024 (Q3 2024), both of the nation’s largest publicly traded laboratories—Labcorp…

Read More

---

Quest Diagnostics Moves to Acquire LifeLabs of Canada

By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue

QUEST DIAGNOSTICS, ALREADY A CLINICAL LABORATORY BEHEMOTH IN THE U.S., is expanding its Nor…

Read More

---